Blueberries for Anti-Inflammatory

Research suggests that blueberries possess meaningful anti-inflammatory properties, with evidence drawn from a range of preclinical animal studies, cell culture experiments, and narrative reviews pointing consistently in a supportive direction. Studies indicate that several compounds found in blueberries — including anthocyanins, pterostilbene, resveratrol, pelargonidin, and monotropein — may reduce inflammatory signaling through multiple biological pathways, such as suppression of NF-κB activity, reductions in inflammatory cytokines, and modulation of oxidative stress, with applications explored across contexts including arthritis, diabetic eye disease, neurological conditions, and gut inflammation. The body of evidence is largely preclinical, relying on animal models and laboratory cell studies, with broader reviews noting that human clinical trial data remains limited and that findings do not always scale consistently with dose or translate directly to humans, as illustrated by one rat study on osteoarthritis that found only modest and inconsistent effects. Overall, the existing research provides a biologically plausible and directionally consistent case for blueberries as a source of anti-inflammatory compounds, but more rigorous human trials are needed before stronger conclusions can be drawn.